Krishnan Ramanathan

Krishnan Ramanathan is an accomplished pharmaceutical executive with extensive experience in drug development and leadership roles. Currently serving as Chief of Staff and Head of Development at the Bill & Melinda Gates Medical Research Institute since February 2025, Krishnan supports the CEO and leads development programs for drug and vaccine candidates. Prior to this role, Krishnan was the VP of Portfolio & Asset Management Head for Immunology at Johnson & Johnson Innovative Medicine, overseeing complex immunology programs. At Novartis, Krishnan held multiple senior positions, including Vice President and Global Program Head, driving initiatives in global health and neuroscience, with a notable success in developing an FDA-approved therapy for multiple sclerosis. Earlier career experience includes senior roles at Nuvelo and GlaxoSmithKline, complemented by advanced degrees in Biomedical Engineering from The Johns Hopkins University.